top of page
Search
The FDA just approved the first direct competitor to a billion-dollar cancer drug
As it stands right now, biosimilars can't be used interchangeably with branded versions, meaning if you were to get a prescription for a...
Lydia Ramsey on uk.BusinessInsider.com
2 min read
Role of brand is 57% more likely to influence a recommendation compared to two years ago
A new report conducted by health branding agency InterbrandHealth measures the value that brands alone provide pharmaceutical companies....
Zach Brooke in Marketing News Weekly
2 min read
What’s in a name? Billions of dollars in tech costs for biosimilars
A new US FDA guidance on how biological products licensed under the Public Health Service Act (PHS Act) need to be named is playing havoc...
PharmaCompass and Ed Silverman on
5 min read
How drug development is speeding up in the cloud
Developing a drug from a promising molecule to a potential life-saver can take more than a decade and cost billions of dollars. Speeding...
By Matthew Wall BBC Technology of Business editor
4 min read
bottom of page